Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Research

• Publication date

  2016-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-15-1538PMID 27197253PMCID PMC4874665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.

  2015cited by this paper
• Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging.

  2015cited by this paper
• Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression.

  2015cited by this paper
• Dual roles of NRF2 in tumor prevention and progression: possible implications in cancer treatment.

  2015cited by this paper
• Expression of B7-H3, a Potential Factor of Tumor Immune Evasion in Combination with the Number of Regulatory T Cells, Affects Against Recurrence-Free Survival in Breast Cancer Patients

  2014cited by this paper
• B7‐H3‐mediated tumor immunology: Friend or foe?

  2014cited by this paper
• Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells

  2014cited by this paper
• The potential of theragnostic ¹²⁴I-8H9 convection-enhanced delivery in diffuse intrinsic pontine glioma.

  2014cited by this paper
• Correlation between B7-H3 expression and matrix metalloproteinases 2 expression in pancreatic cancer

  2013cited by this paper
• HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations.

  2013cited by this paper
• Targeting cellular metabolism to improve cancer therapeutics

  2013cited by this paper
• B7-H3 expression in ductal and lobular breast cancer and its association with IL-10.

  2013cited by this paper
• The Warburg effect then and now: From cancer to inflammatory diseases

  2013cited by this paper
• The emerging "hallmarks" of metabolic reprogramming and immune evasion: distinct or linked?

  2013cited by this paper
• Structure and T cell inhibition properties of B7 family member, B7-H3.

  2013cited by this paper
• Silencing of B7-H3 increases gemcitabine sensitivity by promoting apoptosis in pancreatic carcinoma

  2013cited by this paper
• B7-H3 is Overexpressed in Patients Suffering Osteosarcoma and Associated with Tumor Aggressiveness and Metastasis

  2013cited by this paper
• B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma

  2013cited by this paper
• Characterization of a Soluble B7-H3 (sB7-H3) Spliced from the Intron and Analysis of sB7-H3 in the Sera of Patients with Hepatocellular Carcinoma

  2013cited by this paper
• Murine B7-H3 Is a Co-Stimulatory Molecule for T Cell Activation

  2013cited by this paper
• Intact B7‐H3 signaling promotes allograft prolongation through preferential suppression of Th1 effector responses

  2012cited by this paper
• 2-NBDG Fluorescence Imaging of Hypermetabolic Circulating Tumor Cells in Mouse Xenograft model of Breast Cancer

  2012cited by this paper
• B7‐H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis‐associated genes

  2012cited by this paper
• Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity

  2012cited by this paper
• B7-H3 overexpression in pancreatic cancer promotes tumor progression

  2012cited by this paper
• Metabolic pathways in T cell fate and function.

  2012cited by this paper
• Peroxiredoxin III and Sulfiredoxin Together Protect Mice from Pyrazole-Induced Oxidative Liver Injury

  2012cited by this paper
• B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation

  2011cited by this paper
• B7-H3 and its relevance in cancer; immunological and non-immunological perspectives.

  2011cited by this paper
• B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis

  2010cited by this paper
• FOXP3 expression and overall survival in breast cancer.

  2009cited by this paper
• B7‐H3 is a potent inhibitor of human T‐cell activation: No evidence for B7‐H3 and TREML2 interaction

  2009cited by this paper
• Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses

  2008cited by this paper
• Nrf2-Mediated Transcriptional Induction of Antioxidant Response in Mouse Embryos Exposed to Ethanol in vivo: Implications for the Prevention of Fetal Alcohol Spectrum Disorders

  2008cited by this paper
• The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion.

  2008cited by this paper
• The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

  2008cited by this paper
• Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: Role of B7‐H3 expression and antigen presentation

  2007cited by this paper
• 4IgB7-H3 is the major isoform expressed on immunocytes as well as malignant cells.

  2007cited by this paper
• Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse.

  2006cited by this paper
• Radioimmunotargeting of Human Rhabdomyosarcoma Using Monoclonal Antibody 8H9

  2005cited by this paper
• Molecular Characterization of Human 4Ig-B7-H3, a Member of the B7 Family with Four Ig-Like Domains1

  2004cited by this paper
• The B7 family member B7-H3 preferentially down-regulates T helper type 1–mediated immune responses

  2003cited by this paper
• Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss.

  2003cited by this paper
• Characterization of Mouse and Human B7-H3 Genes1

  2002cited by this paper

• Commentary on “Targeting B7-H3 inhibition-induced activation of fatty acid synthesis boosts anti-B7-H3 immunotherapy in triple-negative breast cancer”

  2026cites this paper
• Association of B7H3 with HIF-1α nuclear expression indicates poor prognosis and therapeutic potential in gastric cancer.

  2026cites this paper
• Pneumococcal H₂O₂ reshapes mitochondrial function and reprograms host cell metabolism

  2025cites this paper
• B7-H3 and CD39 Co-Localization in Gastric Cancer: A Potential Prognostic Biomarker and Potential Dual-Target for Immunotherapy

  2025cites this paper
• The B7-H3 (CD276) pathway: emerging biology and clinical therapeutics.

  2025cites this paper
• B7-H3/CD276: Novel Immune Checkpoint and Jack of All Trades

  2025cites this paper
• Metabolomics in Breast Cancer: From Biomarker Discovery to Personalized Medicine

  2025cites this paper
• Machine Learning Characterization of Immunometabolism in the Tumor Microenvironment and Immunotherapy Responses in Bladder Cancer.

  2025cites this paper
• Research progress of B7-H3 in malignant tumors

  2025cites this paper
• Pneumococcal H2O2 Reshapes Mitochondrial Function and Reprograms Host Cell Metabolism

  2025cites this paper
• Oxidative complexity: The role of ROS in the tumor environment and therapeutic implications.

  2025cites this paper
• The relevance of B7-H3 and tumor-associated macrophages in the tumor immune microenvironment of solid tumors: recent advances.

  2025cites this paper
• B7H3 in Gastrointestinal Tumors: Role in Immune Modulation and Cancer Progression: A Review of the Literature

  2025cites this paper
• Tumor Immunotherapy Targeting B7-H3: From Mechanisms to Clinical Applications

  2025cites this paper
• Unveiling transcriptional mechanisms of B7-H3 in breast cancer stem cells through proteomic approaches

  2025cites this paper
• Involvement of the disulfidptosis-related immune checkpoint gene, CD276, in glioblastoma malignant phenotype and poor prognosis

  2025cites this paper
• B7-H3-mediated deubiquitination stabilizing CYP1B1 expression promotes chemotherapy resistance in colorectal cancer.

  2025cites this paper
• From tumor immunity to precision medicine: the next step in B7-H3/CD276 research

  2025cites this paper
• CD276 as a critical independent biomarker and immune checkpoint inhibitor target in epithelioid mesothelioma-TCGA study

  2025cites this paper
• Identification of the B7-H3 Interaction Partners Using a Proximity Labeling Strategy

  2025cites this paper
• B7-H3 as a Universal Target for Solid Tumor Therapy: Clinical Promise and Biological Complexity.

  2025cites this paper
• High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype

  2024cites this paper
• Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer

  2024cites this paper
• Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity

  2024cites this paper
• Recent developments in immunotherapy for gastrointestinal tract cancers

  2024cites this paper
• B7-H3 enhances colorectal cancer progression by regulating HB-EGF via HIF-1α

  2024cites this paper
• Non-immune functions of B7-H3: bridging tumor cells and the tumor vasculature

  2024cites this paper
• Integrated Bioinformatics Analysis Revealed Immune Checkpoint Genes Relevant to Type 2 Diabetes

  2024cites this paper
• RETRACTED ARTICLE: ArticleNoteCD276 enhances sunitinib resistance in clear cell renal cell carcinoma by promoting DNA damage repair and activation of FAK-MAPK signaling pathway

  2024cites this paper
• Development of a Human B7-H3-Specific Antibody with Activity against Colorectal Cancer Cells through a Synthetic Nanobody Library

  2024cites this paper
• Fully human anti-B7-H3 recombinant antibodies inhibited tumor growth by increasing T cell infiltration.

  2024cites this paper
• B7-H3 suppresses CD8+ T cell immunologic function through reprogramming glycolytic metabolism

  2024cites this paper
• Multi-omics analysis reveals the unique landscape of DLD in the breast cancer tumor microenvironment and its implications for immune-related prognosis

  2024cites this paper
• Overcoming the limitations of immunotherapy in pancreatic ductal adenocarcinoma: Combining radiotherapy and metabolic targeting therapy

  2024cites this paper
• A promising target for breast cancer: B7-H3

  2024cites this paper
• The immune regulatory function of B7-H3 in malignancy: spotlight on the IFN-STAT1 axis and regulation of tumor-associated macrophages

  2024cites this paper
• An optimized IgG-based B7-H3xCD3 bispecific antibody for treatment of gastrointestinal cancers.

  2023cites this paper
• Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis

  2023cites this paper
• Deregulated transcription factors in the emerging cancer hallmarks.

  2023cites this paper
• B7-H3 Inhibitors in Oncology Clinical Trials: A Review

  2023cites this paper
• B7-H3 regulates anti-tumor immunity and promotes tumor development in colorectal cancer.

  2023cites this paper
• Post-Subfunctionalization Functions of HIF-1αA and HIF-1αB in Cyprinid Fish: Fine-Tuning Mitophagy and Apoptosis Regulation Under Hypoxic Stress

  2023cites this paper
• Immune microenvironment dynamics of HER2 overexpressing breast cancer under dual anti-HER2 blockade

  2023cites this paper
• B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention

  2023cites this paper
• Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer.

  2023cites this paper
• Fasting-mimicking diet: a metabolic approach for the treatment of breast cancer

  2023cites this paper
• Targeting Histone 3 Variants Epigenetic Landscape and Inhibitory Immune Checkpoints: An Option for Paediatric Brain Tumours Therapy

  2023cites this paper
• B7-H3 in Brain Malignancies: Immunology and Immunotherapy

  2023cites this paper
• The relevance between hypoxia-dependent spatial transcriptomics and the prognosis and efficacy of immunotherapy in claudin-low breast cancer

  2023cites this paper
• Role of mitochondrial alterations in human cancer progression and cancer immunity

  2023cites this paper
• AGS Gastric Cells: Antioxidant Activity and Metabolic Effects of Phenolic Extracts from Different Monocultivar Virgin Olive Oils

  2023cites this paper
• Clinicopathological features and prognostic value of CD276 expression in head and neck cancer: A meta-analysis.

  2023cites this paper
• Hub gene of disulfidptosis-related immune checkpoints in breast cancer

  2023cites this paper
• Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions.

  2023cites this paper
• [Latest Findings on the Function of Immune Metabolism in Tumor Immunity].

  2023cites this paper
• Transcriptomic and Proteomic of Gastrocnemius Muscle in Peripheral Artery Disease

  2023cites this paper
• The role of tumor metabolism in modulating T-Cell activity and in optimizing immunotherapy

  2023cites this paper
• The mammalian Sterile 20-like kinase 4 (MST4) signaling in tumor progression: Implications for therapy.

  2023cites this paper
• Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies

  2023cites this paper
• New frontiers in immune checkpoint B7-H3 (CD276) research and drug development

  2023cites this paper
• Variable Intrinsic Expression of Immunoregulatory Biomarkers in Breast Cancer Cell Lines, Mammospheres, and Co-Cultures

  2023cites this paper
• To kill a cancer: Targeting the immune inhibitory checkpoint molecule, B7-H3.

  2022cites this paper
• Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer.

  2022cites this paper
• The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development

  2022cites this paper
• Genome-scale CRISPR–Cas9 screen reveals novel regulators of B7-H3 in tumor cells

  2022cites this paper
• A novel strategy to fuel cancer immunotherapy: targeting glucose metabolism to remodel the tumor microenvironment

  2022cites this paper
• Harnessing the immune system by targeting immune checkpoints: Providing new hope for Oncotherapy

  2022cites this paper
• Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas

  2022cites this paper
• Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway

  2022cites this paper
• Deregulated transcription factors in cancer cell metabolisms and reprogramming.

  2022cites this paper
• Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy

  2022cites this paper
• Mutual regulation of lactate dehydrogenase and redox robustness

  2022cites this paper
• Inhibition of the B7-H3 immune checkpoint limits hepatocellular carcinoma progression by enhancing T lymphocyte-mediated immune cytotoxicity in vitro and in vivo

  2022cites this paper
• Manipulating T-cell metabolism to enhance immunotherapy in solid tumor

  2022cites this paper
• B7-H3: A Useful Emerging Diagnostic Marker for Colon Cancer

  2022cites this paper
• Succinate dehydrogenase 5 regulates lung cancer metastasis by reprogramming glucose metabolism

  2021cites this paper
• Immune and metabolic checkpoints blockade: Dual wielding against tumors.

  2021cites this paper
• Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes

  2021cites this paper
• Metabolic checkpoints and novel approaches for immunotherapy against cancer

  2021cites this paper
• The role of B7-H3 in tumors and its potential in clinical application.

  2021cites this paper
• Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression.

  2021cites this paper
• A Novel Prognostic and Predictive Signature for Lung Adenocarcinoma Derived from Combined Hypoxia and Infiltrating Immune Cell-Related Genes in TCGA Patients

  2021cites this paper
• Reduced B7-H3 expression by PAX3-FOXO1 knockdown inhibits cellular motility and promotes myogenic differentiation in alveolar rhabdomyosarcoma

  2021cites this paper
• The Mechanism of Warburg Effect-Induced Chemoresistance in Cancer

  2021cites this paper
• Nrf2 deficiency decreases NADPH from impaired IDH shuttle and pentose phosphate pathway in retinal pigmented epithelial cells to magnify oxidative stress‐induced mitochondrial dysfunction

  2021cites this paper
• B7-H3/CD276: An Emerging Cancer Immunotherapy

  2021cites this paper
• Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies

  2021cites this paper
• The therapeutic implications of immunosuppressive tumor aerobic glycolysis

  2021cites this paper
• B7-H3 and digestive system cancers

  2021cites this paper
• The complexity of tumour angiogenesis based on recently described molecules

  2021cites this paper
• Trim21-mediated HIF-1α degradation attenuates aerobic glycolysis to inhibit renal cancer tumorigenesis and metastasis.

  2021cites this paper
• The Role of CD276 in Cancers

  2021cites this paper
• Reactive oxygen species (ROS): critical roles in breast tumor microenvironment.

  2021cites this paper
• The expression and clinical significance of B7-H3 and miR-145 in lung cancer patients with malignant pleural effusion.

  2020cites this paper
• OTT_A_237841 2215..2224

  2020cites this paper
• The PD-L1 metabolic interactome intersects with choline metabolism and inflammation

  2020cites this paper
• A control theoretic three timescale model for analyzing energy management in mammalian cancer cells

  2020cites this paper
• Visualisation of real-time oral biodistribution of fluorescent labeled self-microemulsifying drug delivery system of olmesartan medoxomil using optical imaging method.

  2020cites this paper
• Metabolism and immunity in breast cancer

  2020cites this paper
• The SIRT6-Autophagy-Warburg Effect Axis in Papillary Thyroid Cancer

  2020cites this paper